General doctors see many women each week, but a lot of violence in their homes stays hidden. This study looked at how doctors spot signs that a woman may be suffering from partner abuse. Researchers talked to 11 family physicians, including three men, across ten clinics. They used made‑up s
Pharmaceutical giant Eli Lilly just dropped $3. 25 billion upfront on a startup called Kelonia Therapeutics, with the potential to pay $7 billion total if everything goes right. The big idea? A treatment that turns your own immune cells into cancer fighters without the usual lab work. Instead of yan
Pharmaceutical firms not included in President Trump's drug pricing agreements are now trying to negotiate their own deals. This move is aimed at avoiding potential tariffs and new pricing regulations. Industry insiders reveal that these companies are reaching out to the White House and Medicare off
Councillors in England hold significant power over local services. Yet, there's a big question: how do they use research to make decisions that affect people's health and well-being? This is where the Health Determinants Research Collaborations (HDRCs) come in. These groups were set up to help local
General Motors is facing a huge financial setback. They just announced a $6 billion loss. This is because they are slowing down their electric vehicle (EV) plans. It's not the first time they've taken a hit. Back in October, they already reported a $1. 6 billion loss for the same reason. This chang
General Kyrylo Budanov, a prominent figure in Ukraine's military intelligence, has been appointed as the new chief of staff by President Volodymyr Zelenskyy. This change comes at a crucial time, as Russia's invasion of Ukraine approaches its fourth year. Budanov takes over from Andrii Yermak, who re
General Motors (GM) is having a stellar year in the stock market. As of the last trading day, its shares have climbed over 55%, reaching an all-time high of more than $80 per share. This is the best performance since the company's comeback after bankruptcy in 2009. Several things are fueling this g
Pharmaceutical giants are making headlines again, but this time, it's not about new drugs. Merck and eight other big players have joined Pfizer, Lilly, and Novo in signing Most Favored Nation (MFN) deals. These agreements aim to make medicines more affordable by tying drug prices to the lowest price
Pharmaceutical stocks have been overlooked for years. But now, AI is changing the game. It can speed up drug development. This could cut the time from 15 years to just 6. That's big news for the industry. Two companies stand out. Becton Dickinson (BDX) and the BlackRock Health Sciences Fund (BME).
General Motors (GM) is feeling the heat in the electric vehicle (EV) market. After a brief surge in sales due to a soon-to-expire federal tax credit, the company is now facing some tough realities. The Trump administration's policies have made things even harder, with changes in regulations, cancele
